Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Mycol Med ; 30(3): 101011, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32693980

ABSTRACT

INTRODUCTION: Otomycosis, a superficial fungal infection of the external auditory canal (EAC), is a disease with exceptionally high prevalence. AIM: The aim of this study was to determine the prevalence of otomycosis, the distribution of causative species and to evaluate epidemiological characteristics of these infections. METHODOLOGY: The patients' data were collected from record book and database of mycological examinations conducted at Public Health Institute Nis, Serbia. In the period from 2014 to 2018 samples of 1287 patients with symptoms and signs of EAC infection were investigated. Standard mycological methods were used for isolation and determination of fungi. RESULTS: High prevalence of otomycosis was determined in examined patients (22.7%). However, the prevalence rates did not differ significantly in the studied period (p=0.931). The majority of patients were diagnosed with only unilateral EAC infection (82.9%). Considering all patients with otomycosis, mold infections caused by the genus Aspergillus (143/48.9%) were more frequent than Candida spp. ear infections (133/45.6%), with Aspergillus niger and Candida аlbicans being predominant causative agents. Mixed Aspergillus and Candida otomycosis was established in 16 (5.5%) patients. Otomycosis was more common in male subjects (26.8%, p=0.003) who also suffered from Aspergillus otomycosis more frequently (17.5%, p<0.001). The prevalence of these infections increases with age (p=0.005), while they do not show seasonal pattern (p>0.05). CONCLUSION: Noted high prevalence of otomycosis, with both yeasts and non-dermatophyte molds acting as infectious agents which require different treatment, implies the necessity for further epidemiological monitoring of this form of superficial mycoses.


Subject(s)
Otomycosis/epidemiology , Otomycosis/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Antifungal Agents/classification , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Aspergillosis/drug therapy , Aspergillosis/epidemiology , Aspergillosis/microbiology , Aspergillus niger/drug effects , Aspergillus niger/isolation & purification , Candida/classification , Candida/drug effects , Candida/isolation & purification , Candida albicans/drug effects , Candida albicans/isolation & purification , Candidiasis/drug therapy , Candidiasis/epidemiology , Candidiasis/microbiology , Female , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Mycological Typing Techniques , Otomycosis/drug therapy , Prevalence , Serbia/epidemiology , Young Adult
2.
Clin Microbiol Infect ; 25(3): 290-309, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29730224

ABSTRACT

BACKGROUND: Parasitic diseases are one of the world's most devastating and prevalent infections, causing millions of morbidities and mortalities annually. In the past, many of these infections have been linked predominantly to tropical or subtropical areas. Nowadays, however, climatic and vector ecology changes, a significant increase in international travel, armed conflicts, and migration of humans and animals have influenced the transmission of some parasitic diseases from 'book pages' to reality in developed countries. It has also been noted that many patients who have never travelled to endemic areas suffer from blood-borne infections caused by protozoa. In the light of existing knowledge, this new trend can be explained by the fact that in the process of migration a large number of asymptomatic carriers become a part of the blood bank donor and transplant donor populations. Accurate and rapid diagnosis represents the crucial weapon in the fight against parasitic infections. AIMS: To review old and new approaches for rapid diagnosis of parasitic infections. SOURCES: Data for this review were obtained through searches of PubMed using combinations of the following terms: parasitological diagnostics, microscopy, lateral flow assays, immunochromatographic assays, multiplex-PCR, and transplantation. CONTENT: In this review, we provide a brief account of the advantages and limitations of rapid methods for diagnosis of parasitic diseases and focus our attention on current and future research in this area. The approximate costs associated with the use of different techniques and their applicability in endemic and non-endemic areas are also discussed. IMPLICATIONS: Microscopy remains the cornerstone of parasitological diagnostics, especially in the field and low-resource settings, and provides epidemiological assessment of parasite burden. However, increased use and availability of point-of-care tests and molecular assays in modern era allow more rapid and accurate diagnoses and increased sensitivity in the identification of parasitic infections.


Subject(s)
Diagnostic Tests, Routine/methods , Diagnostic Tests, Routine/trends , Parasitic Diseases/diagnosis , Parasitology/methods , Parasitology/trends , Animals , Diagnostic Tests, Routine/economics , Humans , Microscopy , Molecular Diagnostic Techniques , Parasites , Parasitic Diseases/epidemiology , Point-of-Care Testing
3.
J Mycol Med ; 28(4): 623-627, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30166063

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate the effectiveness of an alternative treatment in a form of recommended diet modification during and after conventional treatment with antifungals in patients with a chronic form of intestinal Candida overgrowth (ICOG). METHODS: The study included patients with ICOG divided in two subgroups: patients treated with nystatin and recommended diet regime (study group-SG) and the patients treated only with nystatin (control group-CG). After treatment, the mycological control examination and follow-up were performed two times: the first one within ten days after the completion of antifungal treatment, and the second one three months after the treatment initialization. RESULTS: A total of 120 patients finished the study: 80 from the SG and 40 from the CG. At the first mycological control examination of SG patients stools, we noted satisfactory antifungal and symptomatic effect in 56 out of 80 (70.0%) patients and 29 out of 40 (72.5%) in CG, with no statistically significant difference. However, at the second control stool examination, significantly higher percent (85%) of cured patients was recorded after three months of the recommended diet comparing with CG-17 out of 40 (42.5%). CONCLUSION: Results of this pilot study showed that patients who adhered to diet modification during and after treatment with nystatin had better outcomes of ICOG and strongly suggest the need for diet modification in these patients which recommendation could reduce excessive prescription of antifungals.


Subject(s)
Candida/growth & development , Candidiasis/diet therapy , Intestinal Diseases/diet therapy , Adolescent , Adult , Aged , Aged, 80 and over , Antifungal Agents/therapeutic use , Candida/classification , Candidiasis/drug therapy , Candidiasis/microbiology , Candidiasis/pathology , Feces/microbiology , Female , Follow-Up Studies , Humans , Intestinal Diseases/drug therapy , Intestinal Diseases/microbiology , Intestinal Diseases/pathology , Male , Middle Aged , Nystatin/therapeutic use , Pilot Projects , Treatment Outcome , Young Adult
4.
J Mycol Med ; 28(2): 236-248, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29605542

ABSTRACT

Traditional, culture based methods for the diagnosis of fungal infections are still considered as gold standard, but they are time consuming and low sensitive. Therefore, in order to overcome the limitations, many researchers have focused on the development of new immunological and molecular based rapid assays that could enable early diagnosis of infection and accurate identification of fungal pathogens causing superficial and invasive infection. In this brief review, we highlighted the advantages and disadvantages of conventional diagnostic methods and possibility of non-culture based assays in diagnosis of superficial fungal infections and presented the overview on currently available immunochromatographic assays as well as availability of biomarkers detection by immunodiagnostic procedures in prompt and accurate diagnosis of invasive fungal infections. In addition, we presented diagnostic efficiency of currently available molecular panels and researches in this area.


Subject(s)
Fungi/isolation & purification , Immunoassay , Molecular Diagnostic Techniques/methods , Mycoses/diagnosis , Biological Assay , Dermatomycoses/diagnosis , Fungi/pathogenicity , Humans , Immunologic Tests , Invasive Fungal Infections/diagnosis , Polymerase Chain Reaction
5.
Clin Microbiol Infect ; 23(10): 776.e1-776.e5, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28412383

ABSTRACT

OBJECTIVES: A prospective international multicentre surveillance study was conducted to investigate the prevalence and amphotericin B susceptibility of Aspergillus terreus species complex infections. METHODS: A total of 370 cases from 21 countries were evaluated. RESULTS: The overall prevalence of A. terreus species complex among the investigated patients with mould-positive cultures was 5.2% (370/7116). Amphotericin B MICs ranged from 0.125 to 32 mg/L, (median 8 mg/L). CONCLUSIONS: Aspergillus terreus species complex infections cause a wide spectrum of aspergillosis and the majority of cryptic species display high amphotericin B MICs.


Subject(s)
Aspergillosis/epidemiology , Aspergillosis/microbiology , Aspergillus/classification , Aspergillus/isolation & purification , Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Aspergillus/drug effects , Epidemiological Monitoring , Europe/epidemiology , Humans , Microbial Sensitivity Tests , Prevalence , Prospective Studies
6.
Eur J Clin Microbiol Infect Dis ; 33(9): 1623-30, 2014 Sep.
Article in English | MEDLINE | ID: mdl-24791951

ABSTRACT

In order to better understand the epidemiology of fusariosis in Europe, a survey collecting information on the clinical characteristics of the patients infected by Fusarium as well as on the infecting isolates was launched. A total of 76 cases of invasive fusariosis occurring from January 2007 to June 2012 were collected and Fusarium isolates were identified by sequencing the translation elongation factor 1α (TEF) gene. Also, antifungal susceptibility was tested by broth microdilution according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the Etest. Disseminated disease was considered proven in 46 cases and probable in 17 cases. Localised infection was seen in 13 cases. Gibberella fujikuroi species complex (SC), including Fusarium verticillioides and F. proliferatum, and F. solani SC were the most frequent aetiology of disseminated and localised infections, respectively. The crude mortality rate was 46 %, the highest associated with F. solani SC (67 %) and F. proliferatum (62.5 %). A wide range of antifungal susceptibilities was observed. Amphotericin B was the most potent antifungal in vitro, and itraconazole the least effective. The azoles exhibited lower minimum inhibitory concentrations (MICs) against F. verticillioides strains, with posaconazole having a slightly better performance, while F. solani SC isolates were resistant to all three azoles tested. The essential agreement between the Etest and the EUCAST method was 100 % for itraconazole and voriconazole, and 96 % for amphotericin B and posaconazole. In conclusion, we confirm that fusariosis is a rare but severe event in Europe, that G. fujikuroi SC is the predominant cause of deep infections and that different species have different antifungal in vitro susceptibility patterns.


Subject(s)
Fusariosis/epidemiology , Fusarium/isolation & purification , Adolescent , Adult , Aged , Aged, 80 and over , Antifungal Agents/pharmacology , Child , Child, Preschool , Europe/epidemiology , Female , Fungal Proteins/genetics , Fusariosis/microbiology , Fusariosis/mortality , Fusariosis/pathology , Fusarium/classification , Fusarium/drug effects , Fusarium/genetics , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Peptide Elongation Factor 1/genetics , Prospective Studies , Retrospective Studies , Sequence Analysis, DNA , Survival Analysis , Young Adult
7.
J Mycol Med ; 22(3): 243-8, 2012 Sep.
Article in English | MEDLINE | ID: mdl-23518082

ABSTRACT

Recently, geographic variations in resistance to agents commonly used in the treatment of cryptococcosis have been reported. Therefore, the antifungal susceptibilities of 31 clinical isolates of Cryptococcus neoformans, collected in Serbia during 10-year period, were investigated. Strains were isolated from cerebrospinal fluid (n=28) and blood (n=3), from patients with AIDS (n=26), lymphoma (n=4) and kidney transplant recipient (n=1). The minimal inhibitory concentrations (MICs) of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole were determined by the E-test(®) method. The isolates were highly susceptible to amphotericin B (100% susceptibility at MIC<0.5 µg/mL) and 5-fluorocytosine (87.1% susceptibility at MIC ≤ 4 µg/mL). Geometric mean MIC of amphotericin B and 5-fluorocytosine were 0.102 µg/mL and 0.396 µg/mL, respectively. Fluconazole exhibited the lowest activity in vitro (48.4% susceptibility at MIC ≤ 8 µg/mL) with a significant resistance rate. The activity of itraconazole was also decreased (48.4% susceptibility at MIC ≤ 0.25 µg/mL). The geometric mean MIC of fluconazole stood at 15.14 µg/mL and of itraconazole was 0.144 µg/mL. Cross-resistance among azoles was not common (3.2%), but the parallel increase in fluconazole and itraconazole MIC has been observed (P<0.01). The low rate of susceptibility to fluconazole stresses the need for active antifungal surveillance of C. neoformans and of the corresponding data from different geographic regions.


Subject(s)
Amphotericin B/pharmacology , Antifungal Agents/pharmacology , Cross Infection/microbiology , Cryptococcosis/microbiology , Cryptococcus neoformans/drug effects , Drug Resistance, Multiple, Fungal , Fluconazole/pharmacology , Flucytosine/pharmacology , Fungemia/microbiology , Itraconazole/pharmacology , AIDS-Related Opportunistic Infections/complications , Cerebrospinal Fluid/microbiology , Cross Infection/blood , Cross Infection/cerebrospinal fluid , Cross Infection/epidemiology , Cryptococcosis/epidemiology , Cryptococcus neoformans/isolation & purification , Fungemia/epidemiology , Humans , Kidney Transplantation , Lymphoma/complications , Meningitis, Cryptococcal/cerebrospinal fluid , Meningitis, Cryptococcal/epidemiology , Meningitis, Cryptococcal/microbiology , Microbial Sensitivity Tests , Postoperative Complications/microbiology , Serbia/epidemiology
8.
J Helminthol ; 83(2): 129-37, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19379543

ABSTRACT

Human infection by Dirofilaria repens in Serbia has been increasing steadily. The first case was reported in 1971, presented in the form of a single subcutaneous nodule on the back of a young boy. As established by a literature search, eight additional cases were reported until mid-2001. The most frequent site of infection was subcutaneous tissue, with the exception of two cases, in which parasites were found in subconjunctiva and epididymis. Our study, conducted from 2001 to 2008, encompasses 19 new cases. Most of them (63.1%) presented as ocular or periocular infections, in which the parasite was typically found under the conjunctiva. In other cases a parasitic nodule was localized in the temporal region of the head, epididymis, testicle, abdomen, breast or arm. The diagnosis was made by morphological and histological analysis of the extracted intact worms and parasite sections from the tissue. Morphology of the filarial worms was well preserved in more than half of the cases (12/19) and there was never more than one parasite found inside the lesions. Adult worms and immature nematodes were observed in nine and seven cases, respectively. Furthermore, in two cases microfilariae were discovered inside the pseudocoelom, sections of the female reproductive tubes filled with clearly visible larval stages. Dirofilaria repens infection was diagnosed by its morphological features (17/19) or by performing polymerase chain reactions (PCR) using paraffin-embedded tissues (2/19) in the cases where the morphology was insufficient for identification and the parasites had been determined initially as Dirofilaria spp. The amplified 246 bp PCR product showed that the worms were D. repens.


Subject(s)
Dirofilaria/isolation & purification , Dirofilariasis/parasitology , Eye Diseases/parasitology , Skin Diseases, Infectious/parasitology , Subcutaneous Tissue/parasitology , Adult , Aged , Animals , Dirofilaria/anatomy & histology , Dirofilaria/genetics , Dirofilariasis/epidemiology , Dirofilariasis/pathology , Eye Diseases/pathology , Female , Humans , Male , Microfilariae/isolation & purification , Middle Aged , Polymerase Chain Reaction , Serbia/epidemiology , Skin Diseases, Infectious/pathology , Subcutaneous Tissue/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...